Physician profile
John S Son
NPI 1063540946
$2,689.08
in general payments reported to CMS, 2019-2025
6 companies · $1,197 in 2025
The $1,197 reported for 2025 was more than what 93% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $29.76 · 2021: $154 · 2022: $468 · 2023: $667 · 2024: $58.97 · 2025: $1,197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,144 · Travel and Lodging: $779.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,143.80 |
| Travel and Lodging | $779.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,096.66 | 2020-2025 | Cvi Contact Lens, Clariti Contact Lens |
| Bausch & Lomb Americas INC. | $820.87 | 2022-2023 | Infuse, Vyzulta |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $268.28 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $209.17 | 2023-2025 | Acuvue |
| Alcon Vision LLC | $191.14 | 2022-2025 | Precision7, Total30 |
| Optos, INC. | $102.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Son listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.